Silver Intel Report
Miner Company

US Supreme Court rebuffs pharma challenge to Biden-era drug price

By Reuters May 18, 2026 Bearish
US Supreme Court rebuffs pharma challenge to Biden-era drug price
The U.S. Supreme Court declined on Monday to hear a pharmaceutical industry challenge to a plan ​to curb Medicare drug prices adopted during Democratic former President Joe Biden's administration that drugmakers argued ‌illegally forces them to accept steep discounts and jeopardizes innovation.
The U.S. Supreme Court declined on Monday to hear a pharmaceutical industry challenge to a plan ​to curb Medicare drug prices adopted during Democratic former President Joe Biden's administration that drugmakers argued ‌illegally forces them to accept steep discounts and jeopardizes innovation.